Aktis Oncology Inc (AKTS)
Oxford Ledge is still expanding full research coverage of AKTS. Fundamentals and analysis (and, signed in, a delayed quote) are available in the app; the SEC-sourced material below is what we currently have indexed here.
SEC filings
- 10-Q Quarterly financial report (unaudited) 2026-05-11
- 8-K Results of operations / financial condition; Financial statements and exhibits 2026-05-11
- 8-K Departure/election of directors or officers; Regulation FD disclosure; Financial statements and exhibits 2026-04-16
- 8-K Results of operations / financial condition; Financial statements and exhibits 2026-03-30
- 10-K Annual financial report with audited statements 2026-03-30
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for AKTS. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open AKTS in Oxford Ledge — fundamentals, filings, and analysis in the app.
- Browse the stock directory
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Fundamentals are available in the app.